Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplastic Cells, Circulating × Atorvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Prostatic Neoplasms 9 Neoplasms 4 Endometrial Neoplasms 3 Colonic Neoplasms 3 Cardiotoxicity 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Leukemia, Myeloid, Acute 2 Heart Failure 2 Glioblastoma 2 Endometrial Hyperplasia 2 Colorectal Neoplasms 2 Cardiovascular Diseases 2 Venous Thrombosis 1 Smoking 1 Pulmonary Disease, Chronic Obstructive 1 Precancerous Conditions 1 Overall Survival 1 Ototoxicity 1 Neoplastic Cells, Circulating 1 Neoplasms, Plasma Cell 1 Nasopharyngeal Carcinoma 1 Melanoma 1

Interventions

Blood Specimen Collection 23 Surgical Procedures, Operative 4 Liquid Biopsy 4 cabazitaxel 3 Reverse Transcriptase Polymerase Chain Reaction 3 Propofol 3 Flow Cytometry 3 Bevacizumab 3 Trastuzumab 2 Spinal Puncture 2 Sevoflurane 2 Positron Emission Tomography Computed Tomography 2 Pirinitramide 2 Neoadjuvant Therapy 2 Morphine 2 Laparoscopy 2 Gemcitabine 2 Folfox protocol 2 Docetaxel 2 Cisplatin 2 Aspirin 2 Anesthesia, General 2 ribociclib 1 pertuzumab 1 osimertinib 1 lanreotide 1 jinfukang 1 eribulin 1 Watchful Waiting 1 Vinorelbine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02958852 2025-09-10

ABC-SE

Lund University Hospital

Phase 2 Completed

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡